
About JW Pharmaceutical
JW Pharmaceutical is a publicly listed company based in Seoul (South Korea) founded in 1945. Pharmaceutical products and medical devices are developed and manufactured. The company has 1,110 employees. JW Pharmaceutical has completed 1 acquisition, including Euvipharm. Its website jw-pharma.co.kr draws about 83 thousand monthly visits. JW Pharmaceutical offers products and services including νμ½ and νλ°λ¦¬μ€μ . Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is JWμ€μΈμ μ½.
Company details
JW Pharmaceutical was founded in 1945 and is headquartered in Seoul, South Korea. Operations are focused on the pharmaceutical and medical device sectors, where research and development are conducted alongside manufacturing and distribution of medications and equipment. The full product lifecycle is managed, from initial research to market delivery. Collaborations and partnerships are pursued to expand the product portfolio, with emphasis placed on technological advancements in ongoing initiatives.
- Headquarters Seoul, South Korea
- Employees 1,110
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website jw-pharma.co.kr/pharma/ko/main.jsp
- Social LinkedIn
- Legal Name Jw Pharmaceutical Corporation
- Annual Revenue$536.84 M (USD)7.77as on Dec 31, 2025
- Net Profit$40.36 M (USD)-5.5as on Dec 31, 2025
- EBITDA$73.83 M (USD)4.7as on Dec 31, 2025
- Employee Count1,110
- Investments & Acquisitions
Products & Services of JW Pharmaceutical
JW Pharmaceutical offers a comprehensive portfolio of products and services, including 화콜 and 타발리스정.
A cold medicine is provided for symptom relief in common ailments.
A treatment for immune thrombocytopenia is offered to manage blood disorders.
People of JW Pharmaceutical
3 people are tracked at JW Pharmaceutical (3 in leadership); the tracked headcount is 1,110.
| Name | Role | Group |
|---|---|---|
Kyung-Ha Lee | Chairman and Co-Chief Executive Officer | Leadership |
Seiho Chin | Chief Of API Research Center, 센터장 | Leadership |
Meekyung Bae | Chief Of Marketing Strategy Office | Leadership |
Complete people profiles for JW Pharmaceutical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of JW Pharmaceutical
JW Pharmaceutical is a publicly listed company on the KRX with ticker symbol 001060 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date14 Jun 1976
- Listed onKRX: 1060
- Listed entityJW Pharmaceutical Corporation
- Exchange sectorHealth technology
- ISINKR7001060003
- Share price24,950.00 KRW (-1.77% on the day) · 2026-10-14
- Market capitalisation579,876,119,393.00 KRW
- Price to earnings6.0
- EPS (diluted, trailing year)4,159.68 KRW
- Dividend yield2.56%
- Volume (last session)33,513
Financials of JW Pharmaceutical
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 775.30B KRW | 58.29B KRW | 106.62B KRW |
| 2024 | 719.38B KRW | 61.68B KRW | 101.83B KRW |
| 2023 | 748.53B KRW | 35.10B KRW | 119.21B KRW |
| 2022 | 684.35B KRW | 30.31B KRW | 77.33B KRW |
| 2021 | 606.58B KRW | -919.2M KRW | 46.97B KRW |
Detailed financial statements for JW Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by JW Pharmaceutical
JW Pharmaceutical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Euvipharm.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Pharmaceutical ingredients and formulations are manufactured under contract. | euvipharm.com.vn | Long An, Vietnam | 2005 | Sep 2019 | β’β’β’β’ |
Complete acquisition details for JW Pharmaceutical
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of JW Pharmaceutical
3 dated milestones of JW Pharmaceutical across 74 years, from founding to its latest funding, stage changes and deals.
- Founded JW Pharmaceutical is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Euvipharm.
Web traffic of JW Pharmaceutical
The website of JW Pharmaceutical (jw-pharma.co.kr) receives about 83.5K visits a month and ranks #347,046 among all websites worldwide, #292 in Biotechnology and Pharmaceuticals.
- Monthly visits83.5K
▲ 3.6% vs previous month
- Unique visitors22.5K
per month
- Global rank#347,046
among all websites
- Category rank#292
Health · Biotechnology and Pharmaceuticals
- Bounce rate27%
- Pages per visit4.7
- Average visit2 min 38 sec
- DevicesDesktop 70% Β· Mobile 30%
Websites whose visitors overlap most with JW Pharmaceutical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
jwpmall.co.kr | jwpmall.co.kr | 100% | #331,475 | β | |
| kddf.org | 100% | 32.9K | #926,246 | View details | |
kimsonline.co.kr | kimsonline.co.kr | 79% | #214,400 | β | |
| jw-lifescience.co.kr | 76% | 5K | #3,788,374 | View details | |
| health.kr | 74% | #14,868 | View details | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 29 similar websites and full traffic analytics for JW Pharmaceutical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 29 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Jw Pharmaceutical
Complete news archive for JW Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about JW Pharmaceutical
JW Pharmaceutical was founded in 1945.
JW Pharmaceutical is headquartered in Seoul, South Korea.
JW Pharmaceutical has 1,110 employees.
Annual revenue of JW Pharmaceutical is $536.84M as on Dec 31, 2025.
JW Pharmaceutical was founded in 1945 and is headquartered in Seoul, South Korea. Operations are focused on the pharmaceutical and medical device sectors, where research and development are conducted alongside manufacturing and distribution of medications and equipment. The full product lifecycle is managed, from initial research to market delivery. Collaborations and partnerships are pursued to expand the product portfolio, with emphasis placed on technological advancements in ongoing initiatives.
JW Pharmaceutical offers νμ½ and νλ°λ¦¬μ€μ .
Yes, JW Pharmaceutical is publicly traded on KRX under the ticker symbol 001060.
JW Pharmaceutical has made 1 acquisition, including Euvipharm.
JW Pharmaceutical operates through Jwμ€μΈμ μ½.
